1,7-dimethylxanthine has been researched along with Pancreatic Neoplasms in 1 studies
1,7-dimethylxanthine : A dimethylxanthine having the two methyl groups located at positions 1 and 7. It is a metabolite of caffeine and theobromine in animals.
Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cancer cachexia is a multifactorial syndrome characterized by progressive loss of weight and muscle atrophy." | 2.79 | Metabolomics evaluation of serum markers for cachexia and their intra-day variation in patients with advanced pancreatic cancer. ( Azuma, T; Chayahara, N; Fujiwara, Y; Imamura, Y; Kiyota, N; Kobayashi, T; Minami, H; Mukohara, T; Nishiumi, S; Toyoda, M; Yoshida, M, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiwara, Y | 1 |
| Kobayashi, T | 1 |
| Chayahara, N | 1 |
| Imamura, Y | 1 |
| Toyoda, M | 1 |
| Kiyota, N | 1 |
| Mukohara, T | 1 |
| Nishiumi, S | 1 |
| Azuma, T | 1 |
| Yoshida, M | 1 |
| Minami, H | 1 |
1 trial available for 1,7-dimethylxanthine and Pancreatic Neoplasms
| Article | Year |
|---|---|
Metabolomics evaluation of serum markers for cachexia and their intra-day variation in patients with advanced pancreatic cancer.
Topics: Adult; Aged; Biomarkers; Cachexia; Female; Humans; Interleukin-6; Leptin; Male; Metabolomics; Middle | 2014 |